feed-icon-14x14News

ICTR in the News: Transparent Pricing Boosts Business at Outpatient Surgical Centers, Study Suggests


The following article profiles work performed by ICTR researcher Martin Makary, M.D., M.P.H., a professor of surgery at the Johns Hopkins University School of Medicine, who utilized our biostatistic consulting program. In a small study of ambulatory surgical centers across the country, Johns Hopkins quality care researchers found that publicly listing the prices of common operations, such as uncomplicated labor and delivery and tonsillectomies, generally increased business, revenue and patient satisfaction. A report of the findings, published in the April issue of The American Surgeon, suggests that hospitals and other health care providers may want to increase price transparency to … Continue reading

ICTR in the News: Erectile Dysfunction Means Increased Risk for Heart Disease, Regardless of Other Risk Factors


The following article profiles work performed by ICTR researcher Michael Blaha, M.D., M.P.H., associate professor of medicine at the Johns Hopkins School of Medicine in Baltimore, Maryland. Erectile dysfunction (ED) indicates greater cardiovascular risk, regardless of other risk factors, such as cholesterol, smoking and high blood pressure, according new research published in the American Heart Association’s journal Circulation. In the study, which followed more than 1,900 men, ages 60 to 78, over 4 years, those who reported ED were twice as likely to experience heart attacks, cardiac arrests, sudden cardiac death and fatal or non-fatal strokes. Erectile dysfunction (ED) — … Continue reading

1.45 Million Children’s Lives Saved by HiB and Pneumococcal Vaccines Since 2000


Child mortality from Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) bacterial infections in high-burden countries is estimated to have fallen by 51 percent and 90 percent, respectively, during 2000 to 2015 Childhood deaths from two leading bacterial causes of pneumonia and meningitis, pneumococcus and Hib, declined sharply during the period 2000 to 2015, especially as vaccines against these pathogens were introduced in high-burden countries, according to new estimates from a team led by scientists at Johns Hopkins Bloomberg School of Public Health. The findings, published in The Lancet Global Health on June 11, highlight the success of the global fight against … Continue reading

Johns Hopkins Bloomberg School of Public Health Awards Scholarship to Displaced Syrian Pharmacist


Hazem Rihawi’s relief work from Turkey helped save lives during 2016 Aleppo evacuation A Syrian pharmacist who fled his country due to persecution he faced as a relief worker providing essential medications to field hospitals in Aleppo has received a full tuition scholarship to attend the Master of Public Health (MPH) program at the Johns Hopkins Bloomberg School of Public Health. Hazem Rihawi is expected to start the 11-month program in July. Rihawi is the third recipient of the scholarship awarded by the Bloomberg School MPH program in cooperation with the Johns Hopkins Center for Humanitarian Health in response to the worsening … Continue reading

Apply for the 2018 Omnibus Grant


The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 Omnibus Grant Solicitations: ·    SBIR: PA-18-574 ·    ​STTR: PA-18-575   NCATS encourages applications that address a range of focus areas relevant to any stage of translation, from target validation through pre-clinical and clinical evaluation, to intervention implementation and dissemination, including: ·    Drug Discovery and Development ·    Biomedical, Clinical and Health Research Informatics ·    Clinical, Dissemination and Implementation Research The next deadline to apply is Sept. 5, 2018, … Continue reading

ICTR in the News: Grant Funds Collaborative Project to Find New Treatments for Liver Cancer


The following article profiles work performed by ICTR researchers Elana Fertig, Ph.D., assistant professor of oncology and assistant director of The Research Program in Quantitative Sciences, Aleksander Popel, Ph.D., director of the Systems Biology Laboratory and professor of biomedical engineering, oncology, and medicine, Andrew Ewald, Ph.D., professor of cell biology, oncology, and biomedical engineering, and Phuoc Tran, M.D., Ph.D., associate professor of radiation oncology and molecular radiation sciences, oncology and urology. Researchers with the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine received a $3 million grant to use computational modeling and software to understand … Continue reading

Johns Hopkins Kimmel Cancer Center Joins Others in Goal of Eliminating HPV-Related Cancers


The Johns Hopkins Kimmel Cancer Center and more than 70 National Cancer Center-designated cancer centers across the country endorsed the goal of eliminating cancers caused by the human papillomavirus (HPV) with the use of gender-neutral HPV vaccination and evidence-based cancer screening in an open letter to patients and medical providers. The open letter, which was released on June 7, is supported by the American Cancer Society, the American Association for Cancer Research, the American Society for Clinical Oncology, the Prevent Cancer Foundation, the American Society for Preventive Oncology and the Association of American Cancer Institutes. The change in practice could … Continue reading

ICTR in the News: Consumers Beware, High User ‘Star Ratings’ Don’t Mean a Mobile Medical App Works


The following article profiles work performed by ICTR researchers Timothy Plante, M.D., M.H.S., a former fellow at the Johns Hopkins University School of Medicine and current assistant professor of medicine in the Larner College of Medicine at the University of Vermont, and Seth Martin, M.D., M.H.S., assistant professor of medicine at the Johns Hopkins University School of Medicine. By screening 250 user reviews and comments for a once popular — but proven inaccurate — mobile app claiming to change your iPhone into a blood pressure monitor, Johns Hopkins researchers have added to evidence that a high “star rating” doesn’t necessarily … Continue reading

ICTR in the News: Common Diabetes Drug Found Safe for Most Diabetics with Kidney Disease


The following article profiles work performed by ICTR researcher Morgan Grams, M.D., Ph.D., M.H.S., an associate professor of medicine and epidemiology at the Johns Hopkins University School of Medicine. Acidosis related to use of metformin seen only in those with severely decreased kidney function Results of a large-scale study suggest that the oral diabetes drug metformin is safe for most diabetics who also have chronic kidney disease (CKD). The study of more than 150,000 adults by Johns Hopkins Medicine investigators found that metformin’s association with the development of a life-threatening condition called lactic acidosis was seen only among patients with … Continue reading

ICTR in the News: A Call for Doctors to Lead the Charge for Antibiotic-Free Foods


The following article profiles work performed by ICTR researcher Martin Makary, M.D., M.P.H., a professor of surgery at the Johns Hopkins University School of Medicine, who utilized our biostatistics consulting program. Agricultural antibiotics are responsible for roughly 20 percent of resistant infections in humans according to the Centers for Disease Control and Prevention, however, its urgency as a public health concern has been understated. Martin Makary, M.D., M.P.H., a professor of surgery at the Johns Hopkins University School of Medicine, insists that doctors start leading the way for antibiotic-free foods in the same way they advocate for smoking cessation. “Multi-resistant … Continue reading

Funding Opportunity: Johns Hopkins & Kaiser Permanente Research Collaboration Grant


The Kaiser Permanente and Johns Hopkins Medicine Research Collaboration Committeeis actively requesting research proposals to foster collaborative research between the two institutions and address complex and intriguing healthcare and clinical questions vexing our health systems.  Specifically, they are looking for research proposals that are aligned with both organizations’ strategies and present opportunities to prove the synergy of the Kaiser Permanente/Johns Hopkins collaboration.  The hope is to identify and fund proposals that accomplish seminal research utilizing the unique capabilities that only two such organizations as Kaiser Permanente and Johns Hopkins have. Broadly, the goal is to support collaborative epidemiologic, health services and … Continue reading